Severe and symptomatic hyponatraemia after moxifloxacin intake.
Müssig
K
K
Schnauder
G
G
Mörike
K
K
D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001372:Aza Compounds / Q000009:adverse effects*; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced* / Q000628:therapy; D000077266:Moxifloxacin; D011804:Quinolines / Q000009:adverse effects*; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D000959:Antihypertensive Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin